Phase 1 Stomach Cancer Trial, Recruiting (NCT07481357)

Phase 1 Stomach Cancer Trial, Recruiting NCT07481357 Sponsor: Dong-A ST Co., Ltd. Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07481357 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 19 years of age or older
You must have been diagnosed with a specific type of advanced stomach cancer or cancer at the junction of the stomach and food pipe, or advanced pancreatic cancer, that has tested positive for a protein called CLDN18.2 (confirmed through a tissue or cell sample)
Your cancer must be measurable, meaning it can be clearly seen and measured on scans using standard medical guidelines
Your doctor believes you are expected to live for at least 12 weeks

Who may not be able to join:

You have heart or cardiac-related problems (confirm with trial site for specific details)
You have digestive system or stomach/intestinal-related problems (confirm with trial site for specific details)
You have an active and significant infection caused by bacteria, fungi, or a virus, including known Hepatitis B, Hepatitis C, or HIV
You currently have a serious infection in your body that requires antibiotics given through a drip (intravenously)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 82-2-920-8768

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07481357

Sponsor: Dong-A ST Co., Ltd.

Phase: Phase 1

Status: Recruiting

Condition: Stomach Cancer

Trial contact: 82-2-920-8768

More information: https://clinicaltrials.gov/study/NCT07481357

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 19 years of age or older
You must have been diagnosed with a specific type of advanced stomach cancer or cancer at the junction of the stomach and food pipe, or advanced pancreatic cancer, that has tested positive for a protein called CLDN18.2 (confirmed through a tissue or cell sample)
Your cancer must be measurable, meaning it can be clearly seen and measured on scans using standard medical guidelines
Your doctor believes you are expected to live for at least 12 weeks

Who may not be able to join:

You have heart or cardiac-related problems (confirm with trial site for specific details)
You have digestive system or stomach/intestinal-related problems (confirm with trial site for specific details)
You have an active and significant infection caused by bacteria, fungi, or a virus, including known Hepatitis B, Hepatitis C, or HIV
You currently have a serious infection in your body that requires antibiotics given through a drip (intravenously)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Dong-A ST Co., Ltd.

Registry

ClinicalTrials.gov

Start date

18 May 2026

Est. completion

1 February 2028

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Maximum Tolerated Dose (MTD) based on Dose-Limiting Toxicities (DLTs) during Cycle 1; Optimal Biological Effective Dose (OBED) Based on best Overall Response Rate (ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov